Related references
Note: Only part of the references are listed.DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism
Jordana H. Hyman et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR)
Norbert Gleicher et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2013)
DHEA supplementation improves follicular microenviroment in poor responder patients
Paolo Giovanni Artini et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation
Andrea Weghofer et al.
HUMAN REPRODUCTION (2012)
Should androgen supplementation be used for poor ovarian response in IVF?
Sesh Kamal Sunkara et al.
HUMAN REPRODUCTION (2012)
Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels
Ariel Weissman et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Defining ovarian reserve to better understand ovarian aging
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study
A. Wiser et al.
HUMAN REPRODUCTION (2010)
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation
Norbert Gleicher et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Growth Differentiation Factor-9 Mediates Follicle-Stimulating Hormone-Thyroid Hormone Interaction in the Regulation of Rat Preantral Follicular Development
Noriko Kobayashi et al.
ENDOCRINOLOGY (2009)
Premature ovarian failure and dehydroepiandrosterone
Leonidas Mamas et al.
FERTILITY AND STERILITY (2009)
Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders
M Sönmezer et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
A luteal estradiol protocol for expected poor-responders improves embryo number and quality
John L. Frattarelli et al.
FERTILITY AND STERILITY (2008)
Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?
Beverley Vollenhoven et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2008)
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function
David Barad et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2007)
Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist
Mustafa Bahceci et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells
TE Hickey et al.
BIOLOGY OF REPRODUCTION (2005)
Agonist flare-up versus antagonist in the management of poor responders undergoing in vitro fertilization treatment
KA Mohamed et al.
FERTILITY AND STERILITY (2005)
Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series
PR Casson et al.
HUMAN REPRODUCTION (2000)
Share Paper
